Business & regional news

Medtronic will present the latest data on its MiniMed™ 780G insulin pump and showcase the company’s latest CareLink™ experience launching globally this month

Medtronic, a global leader in medical technology, announced today that it has received U.S. FDA Breakthrough Device designation for Infuse™ bone graft with an intervertebral fusion device and a...

Offering comprehensive support for precise sub-lobar resection surgeries for patients with early-stage lung cancer, and providing treatment that leads to improvements in patients’ prognosis

The company is pursuing hernia and gynecology indications along with urology as it progresses plans to bring choice in robotic surgery technology and partnership to the U.S. Medtronic, a global...

Preliminary findings of the first and only head-to-head trial comparing standard-of-care CT-guided biopsy with electromagnetic navigation bronchoscopy (ENB) for the diagnosis of lung nodules demonstrate non-inferiority and fewer complications when using ENB

Medtronic has modernized its Reveal LINQ™ Insertable Cardiac Monitor (ICM) with artificial intelligence capabilities to reduce false alerts

Symplicity Spyral is the first renal denervation technology to be approved by the National Medical Products Administration; new, innovative, minimally invasive procedure uses radiofrequency energy to help reduce high blood pressure

Medtronic, the global leader in healthcare technology, today announced the release of important clinical outcomes in two leading transcatheter valve therapies. The results for these studies were...

Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy. Medtronic, a global leader in healthcare technology, today announced the results of...

Honorary day celebrates Medtronic roots, 75th anniversary year

Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems. Medtronic, a global leader in healthcare technology,...

Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus™ valve

Patient advocate and youth entrepreneur Grace Bowyer will join company executives, shining light on the critical importance for colon cancer screening

Medtronic today announced it received a license from Health Canada for its Symplicity Spyral™ multi-electrode Renal Denervation (RDN) System. This is indicated for the management of essential...

CRT 2024: Evolut TAVR is a safe, effective, and economically cost-effective treatment option for low-risk severe aortic stenosis patients compared to surgery up to four years

Katie will join colorectal cancer screening advocates and Medtronic leaders in a panel conversation, highlighting new data that reveals a stark gap in colorectal cancer awareness, as well as how AI is making the deadly disease more detectable, preventable

Medtronic, a global leader in medical technology, announced today the launch of the new UNiD™ ePRO service in the United States. This solution will change the way patient outcomes are collected...

Annual list highlights organizations leading the way in business integrity

• MEIC is the largest Research and Development (R&D) center outside the US. for Medtronic
• A 250,000 sq. ft. facility devoted to healthcare technology R&D in Hyderabad.

Doubled probe count enables multi-level spine tumor ablations for increased flexibility and efficiency Medtronic plc, a global leader in healthcare technology, today announced that it has received...

Medtronic will unveil the MiniMed™ 780G system with Simplera Sync™, a new disposable, all-in-one sensor.*

STROKE AF study shows long-term continuous cardiac monitoring delivers strong economic value driven by fewer projected lifetime strokes

FEBRUARY 6, 2024 – Hall of Fame Health and the Cranial and Spinal Technologies business of Medtronic, a global medical technology leader, today are announcing a partnership to advance health...

Physician feedback confirms clinical evidence: safe, efficient, and effective treatment offers most versatile new option for atrial fibrillation

86% of subjects preferred closed-loop SCS in a multicenter, randomized, crossover, single blind study of Medtronic’s investigational closed-loop SCS system at one month

24-month European RCT data demonstrates long-term superiority of DTM™ SCS compared with conventional medical management (CMM) for indicated chronic back pain patients not eligible for spine surgery

The Schwab Foundation for Social Entrepreneurship, a sister organization of the World Economic Forum (WEF), announced at WEF’s annual meeting in Davos today that Ruchika Singhal, president of Medtronic LABS, is the 2024 “Corporate Social Innovator of the Year.”

Strong environmental, social, and governance (ESG) management and performance result in continued inclusion on the Dow Jones Sustainability World Index

The next-generation DBS technology is now available in a rechargeable option

The PenditureTM Left Atrial Appendage (LAA) Exclusion System is
for the exclusion of the LAA in patients undergoing a concomitant cardiac surgery procedure.

Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation

AHA23: Artificial intelligence (AI) applied to LINQ II™ ICMs reduce AF and pause (syncope) false alerts that can save clinics in the U.S. more than 400 hours per year

NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation

New guidelines will expand access to automated insulin delivery technology among wider population.

Next-Gen Evolut FX TAVI system enhances procedure ease-of-use, visualization, and predictability

Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.